Literature DB >> 26481501

Why more is less and less is more when it comes to ovarian stimulation.

Zeev Blumenfeld1.   

Abstract

PURPOSE: The purpose of the present study is to describe the possible mechanisms which may explain the apparent paradox of "less is more." Mild ovarian stimulation for in vitro fertilization (IVF) minimizes ovarian hyperstimulation syndrome (OHSS) and multiple gestations without compromising the pregnancy rate (PR).
METHODS: The pertinent English literature (PubMed) addressing mild stimulation for IVF/assisted reproductive technology (ART) and publications addressing "mild" or "soft" controlled ovarian stimulation (COS) vs conventional COS for IVF, OHSS, natural cycle IVF, and IVF outcome in association with COS was searched.
RESULTS: Four possible mechanisms can be put forward to explain the apparent paradox of "less is more." (1) In the natural or mild stimulation cycles, the healthiest follicles are selected by the principle of "quality for quantity"; (2) high estradiol (E2) in the late follicular phase significantly correlated with higher rates of small for gestational age (SGA) and low-birth-weight (LBW) neonates; (3) anti-Mullerian hormone (AMH), LH, testosterone, and E(2) are significantly higher in natural cycle (NC)-IVF than in stimulated IVF follicles, suggesting an alteration of the follicular metabolism in stimulated cycles; and (4) supraphysiological E(2) may increase the growth hormone-binding protein (GH-BP) bio-neutralizing GH and diminishing the resultant insulin-like growth factor (IGF) levels, necessary for optimal synergism with follicle-stimulating hormone (FSH).
CONCLUSIONS: It is suggested to aim at the retrieval of around eight to ten eggs. Mild stimulation should be the common practice for IVF. In cases where more than ten ova are retrieved or high E(2) levels are reached, either intentionally or unintentionally, "freeze-all policy" should be considered and embryo transfer (ET) done in a subsequent natural cycle.

Entities:  

Keywords:  Growth hormone-binding protein (GH-BP); In vitro fertilization (IVF); Mild controlled ovarian stimulation (COS); Minimal ovarian stimulation; Ovarian hyperstimulation syndrome (OHSS)

Mesh:

Substances:

Year:  2015        PMID: 26481501      PMCID: PMC4681727          DOI: 10.1007/s10815-015-0599-7

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  61 in total

Review 1.  The science behind 25 years of ovarian stimulation for in vitro fertilization.

Authors:  Nick S Macklon; Richard L Stouffer; Linda C Giudice; Bart C J M Fauser
Journal:  Endocr Rev       Date:  2006-01-24       Impact factor: 19.871

2.  Follicular-fluid anti-Mullerian hormone concentrations are predictive of assisted reproduction outcome in PCOS patients.

Authors:  Recai Pabuccu; Cemil Kaya; Gamze Sinem Cağlar; Efser Oztas; Hakan Satiroglu
Journal:  Reprod Biomed Online       Date:  2009-11       Impact factor: 3.828

3.  Large baby syndrome in singletons born after frozen embryo transfer (FET): is it due to maternal factors or the cryotechnique?

Authors:  A Pinborg; A A Henningsen; A Loft; S S Malchau; J Forman; A Nyboe Andersen
Journal:  Hum Reprod       Date:  2014-01-09       Impact factor: 6.918

4.  Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.

Authors:  Sesh Kamal Sunkara; Vivian Rittenberg; Nick Raine-Fenning; Siladitya Bhattacharya; Javier Zamora; Arri Coomarasamy
Journal:  Hum Reprod       Date:  2011-05-10       Impact factor: 6.918

Review 5.  Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.

Authors:  Mohamed A F M Youssef; Fulco Van der Veen; Hesham G Al-Inany; Monique H Mochtar; Georg Griesinger; Mohamed Nagi Mohesen; Ismail Aboulfoutouh; Madelon van Wely
Journal:  Cochrane Database Syst Rev       Date:  2014-10-31

6.  Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo.

Authors:  D Valbuena; J Martin; J L de Pablo; J Remohí; A Pellicer; C Simón
Journal:  Fertil Steril       Date:  2001-11       Impact factor: 7.329

7.  Suppression of extravillous trophoblast vascular endothelial growth factor expression and uterine spiral artery invasion by estrogen during early baboon pregnancy.

Authors:  Thomas W Bonagura; Gerald J Pepe; Allen C Enders; Eugene D Albrecht
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

8.  Growth hormone-binding protein (GH-BP) levels in follicular fluid from human preovulatory follicles: correlation with serum GH-BP levels.

Authors:  T Amit; M Dirnfeld; R J Barkey; I Peleg; H Hacham; H Abramovici; Z Blumenfeld
Journal:  J Clin Endocrinol Metab       Date:  1993-07       Impact factor: 5.958

9.  A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.

Authors:  Femke P Hohmann; Nicholas S Macklon; Bart C J M Fauser
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

10.  Coming soon to your clinic: patient-friendly ART.

Authors:  Guido Pennings; Willem Ombelet
Journal:  Hum Reprod       Date:  2007-06-21       Impact factor: 6.918

View more
  4 in total

Review 1.  What is the contribution of embryo-endometrial asynchrony to implantation failure?

Authors:  Wan-Tinn Teh; John McBain; Peter Rogers
Journal:  J Assist Reprod Genet       Date:  2016-08-01       Impact factor: 3.412

2.  Cumulative live birth and surplus embryo incidence after frozen-thaw cycles in PCOS: how many oocytes do we need?

Authors:  Yuan-Hui Chen; Qian Wang; Ya-Nan Zhang; Xiao Han; Dong-Han Li; Cui-Lian Zhang
Journal:  J Assist Reprod Genet       Date:  2017-06-03       Impact factor: 3.412

3.  Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study.

Authors:  Khalid M Salama; Hesham M Abo Ragab; Mohammed F El Sherbiny; Ali A Morsi; Ibrahim I Souidan
Journal:  BMC Womens Health       Date:  2017-11-13       Impact factor: 2.809

4.  Choosing Wisely Canada: Canadian fertility and andrology society's list of top items physicians and patients should question in fertility medicine.

Authors:  C A Jones; L Hawkins; Catherine Friedman; J Hitkari; E McMahon; K B Born
Journal:  Arch Gynecol Obstet       Date:  2022-03-12       Impact factor: 2.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.